Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Xi Yang

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Biology|October 30, 2013
Radioprotectants to reduce the risk of radiation-induced carcinogenesisCaspian Oliai, Li-Xi Yang
Anticancer Research|August 10, 2002
Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapyMonte Fisher, Li-Xi Yang
Anticancer Research|January 31, 2012
Improved radiotherapy for primary and secondary liver cancer: stereotactic body radiation therapyChad Tao, Li-Xi Yang
Anticancer Research|November 11, 2006
New molecular mechanisms of action of camptothecin-type drugsKathleen Legarza, Li-Xi Yang
Anticancer Research|May 13, 2015
Recent developments in radiosensitizationJustin Linam, Li-Xi Yang
Anticancer Research|October 15, 2010
Novel chemoradiosensitizers for cancer therapyPaul Page, Li-Xi Yang
Anticancer Research|October 30, 2004
Centrosomes--their role in tumors and cancer therapySimon Ro, Li-Xi Yang
In Vivo (Athens, Greece)|March 31, 2005
Novel camptothecin derivativesKathleen Legarza, Li-Xi Yang
Mini Reviews in Medicinal Chemistry|May 17, 2005
Synthesis and pharmacology of new camptothecin drugsRussell W Driver, Li-Xi Yang
Current Pharmaceutical Design|May 14, 2008
Design, synthesis and development of novel camptothecin drugsSiong Tern Liew, Li-Xi Yang
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Biology|October 30, 2013
Radioprotectants to reduce the risk of radiation-induced carcinogenesisCaspian Oliai, Li-Xi Yang
Anticancer Research|August 10, 2002
Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapyMonte Fisher, Li-Xi Yang
Anticancer Research|January 31, 2012
Improved radiotherapy for primary and secondary liver cancer: stereotactic body radiation therapyChad Tao, Li-Xi Yang
Anticancer Research|November 11, 2006
New molecular mechanisms of action of camptothecin-type drugsKathleen Legarza, Li-Xi Yang
Anticancer Research|May 13, 2015
Recent developments in radiosensitizationJustin Linam, Li-Xi Yang
Anticancer Research|October 15, 2010
Novel chemoradiosensitizers for cancer therapyPaul Page, Li-Xi Yang
Anticancer Research|October 30, 2004
Centrosomes--their role in tumors and cancer therapySimon Ro, Li-Xi Yang
In Vivo (Athens, Greece)|March 31, 2005
Novel camptothecin derivativesKathleen Legarza, Li-Xi Yang
Mini Reviews in Medicinal Chemistry|May 17, 2005
Synthesis and pharmacology of new camptothecin drugsRussell W Driver, Li-Xi Yang
Current Pharmaceutical Design|May 14, 2008
Design, synthesis and development of novel camptothecin drugsSiong Tern Liew, Li-Xi Yang
Pageof 3